ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $226,830 | -39.3% | 8,442 | -19.4% | 0.00% | – |
Q2 2023 | $373,672 | -72.4% | 10,479 | -68.6% | 0.00% | -100.0% |
Q4 2022 | $1,354,024 | +15.3% | 33,383 | -6.0% | 0.00% | 0.0% |
Q3 2022 | $1,174,000 | -8.4% | 35,508 | -2.4% | 0.00% | 0.0% |
Q2 2022 | $1,281,000 | -24.7% | 36,376 | -1.7% | 0.00% | 0.0% |
Q1 2022 | $1,702,000 | -34.0% | 36,997 | -4.9% | 0.00% | 0.0% |
Q4 2021 | $2,579,000 | -5.8% | 38,898 | -11.3% | 0.00% | -50.0% |
Q3 2021 | $2,737,000 | -18.7% | 43,840 | +7.9% | 0.00% | 0.0% |
Q2 2021 | $3,365,000 | +30.1% | 40,627 | +4.2% | 0.00% | 0.0% |
Q1 2021 | $2,586,000 | +0.5% | 38,995 | +16.4% | 0.00% | 0.0% |
Q4 2020 | $2,572,000 | +77.1% | 33,515 | -0.6% | 0.00% | +100.0% |
Q3 2020 | $1,452,000 | -8.4% | 33,714 | -8.2% | 0.00% | -50.0% |
Q2 2020 | $1,586,000 | +45.1% | 36,718 | -3.3% | 0.00% | +100.0% |
Q1 2020 | $1,093,000 | -63.4% | 37,974 | -19.4% | 0.00% | -66.7% |
Q4 2019 | $2,990,000 | +214.1% | 47,142 | +39.5% | 0.00% | +200.0% |
Q3 2019 | $952,000 | +12.1% | 33,800 | +5.5% | 0.00% | 0.0% |
Q2 2019 | $849,000 | +48.9% | 32,047 | +3.2% | 0.00% | 0.0% |
Q1 2019 | $570,000 | +43.2% | 31,051 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $398,000 | – | 32,034 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |